[
    {
        "gene_symbol": "MLH1",
        "mmr_immunohistochemistry": {
            "test_name": "Mismatch Repair Immunohistochemistry (IHC)",
            "definition": "Immunostaining of tumor tissue to evaluate expression of key mismatch repair proteins: MLH1, MSH2, MSH6, and PMS2.",
            "testing": "Tests reporting presence/absence of defect",
            "implication": "Loss of expression of one or more proteins suggests defective mismatch repair (dMMR).",
            "clinical_relevance": "Often used in parallel with MSI testing or as a screening tool for Lynch syndrome. Can help resolve indeterminate MSI results or cases with low tumor content.",
            "report_language": [
                "Loss of MLH1 and PMS2 expression is consistent with MMR-deficiency",
                "Intact MMR protein expression suggests MMR-proficient (pMMR)."
            ],
            "underlying_result": "All four proteins show retained (normal) expression."
        },
        "mmr_germline": {
            "test_name": "Germline MMR Gene Testing (Hereditary Cancer Panel)",
            "definition": "Sequencing of MLH1, MSH2, MSH6, PMS2, and EPCAM to identify germline mutations causing Lynch syndrome.",
            "implication": "Positive results confirm inherited cancer predisposition.",
            "clinical_relevance": "Required for definitive diagnosis of cancer syndromes. Guides family counseling and surveillance recommendations.",
            "report_language": [
                "Pathogenic variant in [add specific gene] detected is consistent with Lynch syndrome.",
                "No pathogenic variant detected does not rule out all causes of MSI-H/dMMR.",
                "Variants of Uncertain Significance (VUS) detected may require further study or family testing."
            ],
            "underlying_result": "Individual variant calls and classifications for these 4 genes (sometimes other combinations also)"
        }
    },
    {
        "gene_symbol": "MSH2",
        "mmr_immunohistochemistry": {
            "test_name": "Mismatch Repair Immunohistochemistry (IHC)",
            "definition": "Immunostaining of tumor tissue to evaluate expression of key mismatch repair proteins: MLH1, MSH2, MSH6, and PMS2.",
            "testing": "Tests reporting presence/absence of defect",
            "implication": "Loss of expression of one or more proteins suggests defective mismatch repair (dMMR).",
            "clinical_relevance": "Often used in parallel with MSI testing or as a screening tool for Lynch syndrome. Can help resolve indeterminate MSI results or cases with low tumor content.",
            "report_language": [
                "Loss of MLH1 and PMS2 expression is consistent with MMR-deficiency",
                "Intact MMR protein expression suggests MMR-proficient (pMMR)."
            ],
            "underlying_result": "All four proteins show retained (normal) expression."
        },
        "mmr_germline": {
            "test_name": "Germline MMR Gene Testing (Hereditary Cancer Panel)",
            "definition": "Sequencing of MLH1, MSH2, MSH6, PMS2, and EPCAM to identify germline mutations causing Lynch syndrome.",
            "implication": "Positive results confirm inherited cancer predisposition.",
            "clinical_relevance": "Required for definitive diagnosis of cancer syndromes. Guides family counseling and surveillance recommendations.",
            "report_language": [
                "Pathogenic variant in [add specific gene] detected is consistent with Lynch syndrome.",
                "No pathogenic variant detected does not rule out all causes of MSI-H/dMMR.",
                "Variants of Uncertain Significance (VUS) detected may require further study or family testing."
            ],
            "underlying_result": "Individual variant calls and classifications for these 4 genes (sometimes other combinations also)"
        }
    },
    {
        "gene_symbol": "MSH6",
        "mmr_immunohistochemistry": {
            "test_name": "Mismatch Repair Immunohistochemistry (IHC)",
            "definition": "Immunostaining of tumor tissue to evaluate expression of key mismatch repair proteins: MLH1, MSH2, MSH6, and PMS2.",
            "testing": "Tests reporting presence/absence of defect",
            "implication": "Loss of expression of one or more proteins suggests defective mismatch repair (dMMR).",
            "clinical_relevance": "Often used in parallel with MSI testing or as a screening tool for Lynch syndrome. Can help resolve indeterminate MSI results or cases with low tumor content.",
            "report_language": [
                "Loss of MLH1 and PMS2 expression is consistent with MMR-deficiency",
                "Intact MMR protein expression suggests MMR-proficient (pMMR)."
            ],
            "underlying_result": "All four proteins show retained (normal) expression."
        },
        "mmr_germline": {
            "test_name": "Germline MMR Gene Testing (Hereditary Cancer Panel)",
            "definition": "Sequencing of MLH1, MSH2, MSH6, PMS2, and EPCAM to identify germline mutations causing Lynch syndrome.",
            "implication": "Positive results confirm inherited cancer predisposition.",
            "clinical_relevance": "Required for definitive diagnosis of cancer syndromes. Guides family counseling and surveillance recommendations.",
            "report_language": [
                "Pathogenic variant in [add specific gene] detected is consistent with Lynch syndrome.",
                "No pathogenic variant detected does not rule out all causes of MSI-H/dMMR.",
                "Variants of Uncertain Significance (VUS) detected may require further study or family testing."
            ],
            "underlying_result": "Individual variant calls and classifications for these 4 genes (sometimes other combinations also)"
        }
    },
    {
        "gene_symbol": "PMS2",
        "mmr_immunohistochemistry": {
            "test_name": "Mismatch Repair Immunohistochemistry (IHC)",
            "definition": "Immunostaining of tumor tissue to evaluate expression of key mismatch repair proteins: MLH1, MSH2, MSH6, and PMS2.",
            "testing": "Tests reporting presence/absence of defect",
            "implication": "Loss of expression of one or more proteins suggests defective mismatch repair (dMMR).",
            "clinical_relevance": "Often used in parallel with MSI testing or as a screening tool for Lynch syndrome. Can help resolve indeterminate MSI results or cases with low tumor content.",
            "report_language": [
                "Loss of MLH1 and PMS2 expression is consistent with MMR-deficiency",
                "Intact MMR protein expression suggests MMR-proficient (pMMR)."
            ],
            "underlying_result": "All four proteins show retained (normal) expression."
        },
        "mmr_germline": {
            "test_name": "Germline MMR Gene Testing (Hereditary Cancer Panel)",
            "definition": "Sequencing of MLH1, MSH2, MSH6, PMS2, and EPCAM to identify germline mutations causing Lynch syndrome.",
            "implication": "Positive results confirm inherited cancer predisposition.",
            "clinical_relevance": "Required for definitive diagnosis of cancer syndromes. Guides family counseling and surveillance recommendations.",
            "report_language": [
                "Pathogenic variant in [add specific gene] detected is consistent with Lynch syndrome.",
                "No pathogenic variant detected does not rule out all causes of MSI-H/dMMR.",
                "Variants of Uncertain Significance (VUS) detected may require further study or family testing."
            ],
            "underlying_result": "Individual variant calls and classifications for these 4 genes (sometimes other combinations also)"
        }
    },
    {
        "gene_symbol": "EPCAM",
        "mmr_germline": {
            "test_name": "Germline MMR Gene Testing (Hereditary Cancer Panel)",
            "definition": "Sequencing of MLH1, MSH2, MSH6, PMS2, and EPCAM to identify germline mutations causing Lynch syndrome.",
            "implication": "Positive results confirm inherited cancer predisposition.",
            "clinical_relevance": "Required for definitive diagnosis of cancer syndromes. Guides family counseling and surveillance recommendations.",
            "report_language": [
                "Pathogenic variant in [add specific gene] detected is consistent with Lynch syndrome.",
                "No pathogenic variant detected does not rule out all causes of MSI-H/dMMR.",
                "Variants of Uncertain Significance (VUS) detected may require further study or family testing."
            ],
            "underlying_result": "Individual variant calls and classifications for these 4 genes (sometimes other combinations also)"
        }
    }
]